Jim Cramer

Cramer’s lightning round: I like Entegris
Business

Cramer’s lightning round: I like Entegris

Entegris Inc: “I like Entegris. It’s very out of favor, it’s got a little too high multiple, but it does a lot of nuts and bolts that you need to make semis, so that’s okay by me.” Henry Schein Inc: “I like the company. It’s very plain vanilla, nothing really exciting about it, but that’s […]

Read More
Jim Cramer says Disney should allow Nelson Peltz to join its board
Business

Jim Cramer says Disney should allow Nelson Peltz to join its board

CNBC’s Jim Cramer on Thursday called on Disney to give activist investor Nelson Peltz a seat on its board. “It’s the board, the stewards, who haven’t done a good job. Not the shareholders, and not Peltz. Now someone like Peltz, who’s been tremendously successful, wants to join them and they act like that’s a problem,” […]

Read More
Nelson Peltz’s attempt to join Disney’s board could force much-needed accountability
Business

Nelson Peltz’s attempt to join Disney’s board could force much-needed accountability

If Nelson Peltz were to win his fight to join Walt Disney ‘s (DIS) board of directors, the activist investor could force a level of accountability at the company that’s sorely needed. Peltz is the CEO and founder of Trian Partners, an investment firm that owns 9.4 million shares of Disney valued at nearly $940 […]

Read More
Jim Cramer’s Investing Club assembly Thursday: December CPI, Disney, Wells Fargo
Finance

Jim Cramer’s Investing Club assembly Thursday: December CPI, Disney, Wells Fargo

Each and every weekday the CNBC Investing Club with Jim Cramer retains a “Early morning Assembly” livestream at 10:20 a.m. ET. Here is a recap of Thursday’s essential times. December CPI lifts shares, optimism about the Fed Nelson Peltz’s observe history speaks for by itself Anticipations for Wells Fargo’s impending earnings 1. December CPI is […]

Read More
Cramer’s lightning round: I would hold onto Biomarin Pharmaceutical
Business

Cramer’s lightning round: I would hold onto Biomarin Pharmaceutical

Kura Oncology Inc: “That’s it, one of these personalized oncology companies. Here’s what I say about those. Some of them are going to work, and some are not.” Jim Cramer’s Guide to Investing Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter. Source

Read More
Jim Cramer likes these 5 ‘reasonably’ valued stocks in the S&P 500
Business

Jim Cramer likes these 5 ‘reasonably’ valued stocks in the S&P 500

CNBC’s Jim Cramer on Wednesday offered investors a list of stocks that he believes could be great additions to portfolios. “We only want … stocks if they’re reasonably valued because this market has very little patience for anything expensive,” he said. Here is his list: Earnings season kicks into high gear Friday with reports from […]

Read More
Charts suggest the market could rally for the next couple of months, Jim Cramer says
Business

Charts suggest the market could rally for the next couple of months, Jim Cramer says

CNBC’s Jim Cramer on Wednesday said that the markets’ recent gains could become a sustained rally. “The charts, as interpreted by Larry Williams … suggest that the market could have a very nice run over the next couple of months,” he said. related investing news Stocks rose on Wednesday, continuing the year’s strong start as […]

Read More
Jim Cramer explains why the December CPI number is a ‘big deal’
Business

Jim Cramer explains why the December CPI number is a ‘big deal’

CNBC’s Jim Cramer on Wednesday broke down the significance of the December consumer price index report for investors. “What makes tomorrow’s consumer price index number a big deal? Simple: We’re looking to see if we’re nearing the end of the period where companies can raise prices with impunity,” he said. Cramer previously said that the […]

Read More
Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential
Health

Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential

The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant looks to advance drugs in its stellar pipeline. Executives detailed reasons for optimism at a major industry gathering this week. “We’re looking at another unprecedented year for Lilly,” CFO Anat Ashkenazi said Tuesday night at JPMorgan’s annual health-care conference. “A strong year […]

Read More
Cramer’s lighting round: Energy Transfer is a very good stock
Business

Cramer’s lighting round: Energy Transfer is a very good stock

Nvidia Corp: “Nvidia is a terrific company but it sells at a very high price-to-earnings multiple. … We have pulled back a little bit [for the Charitable Trust].” Blackstone Minerals Ltd: “I do not know Blackstone Minerals. I am going to have to do some more work on that situation.” EVgo Inc: “Our biggest fear […]

Read More